Identification of novel third-generation synthetic cannabinoids in products by ultra-performance liquid chromatography and time-of-flight mass spectrometry

Journal of Analytical Toxicology

Volumn 37, Issue 8, 2013, Pages 517-525

  Shanks, Kevin G ^a   Behonick, George S ^a   Dahn, Tim ^a   Terrel, Andrea ^a  

^a AIT Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(1 PENTYL 1H INDOL 3 YL)(2,2,3,3 TETRAMETHYLCYCLOPROPYL) METHANONE; [1 (2 MORPHOLIN 4 YLETHYL) 1H INDOLE 3 YL] (2,2,3,3, THETRAMETHYLCYCLOPROPYL)METHANONE; [1 (5 FLUOROPENTYL) 1H INDOL 3 YL](2,2,3,3 TETRAMETHYLCYCLOPROPYL) METHANONE; [1 (5 FLUOROPENTYL) 1H INDOL 3 YL](4 METHYL 1 NAPTHALENYL)METHANONE; [3 (3 CARBAMOYLPHENYL)PHENYL] N CYCLOHEXYCARBAMATE; CANNABINOID; CONTROLLED SUBSTANCE; INDOLE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHROMATOGRAPHY; CONTROLLED STUDY; CRIME; HERBAL MEDICINE; INCENSE; LAW ENFORCEMENT; PREVALENCE; QUALITATIVE ANALYSIS; SOLVENT EXTRACTION; TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

CANNABINOIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DESIGNER DRUGS; GOVERNMENT REGULATION; INDIANA; MASS SPECTROMETRY; MOLECULAR STRUCTURE; PLANT PREPARATIONS; QUALITY CONTROL; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE DETECTION;

EID: 84888872008     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bkt062     Document Type: Article

References (22)

1. Hudson, S., Ramsey, J., King, L., Timbers, S., Maynard, S., Dargan, P.I. et al. (2010) Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in 'herbal high' products. Journal of Analytical Toxicology, 34, 252-260.
2. Uchiyama, N., Kawamura, M., Kikura-Hanajiri, R., Goda, Y. (2011) Identification and quantitation of two cannabimimetic phenylacetylindoles JWH-251 and JWH-250, and four cannabimimetic naphthoylindoles JWH-081, JWH-015, JWH-200, and JWH-073 as designer drugs in illegal products. Forensic Toxicology, 29, 25-37.
3. Logan, B.K., Reinhold, L.E., Xu, A., Diamond, F.X. (2012) Identification of synthetic cannabinoids in herbal incense blends in the United States. Journal of Forensic Sciences, 57, 1168-1180.
4. Shanks, K., Dahn, T., Behonick, G., Terrell, A. (2012) Detection of synthetic cannabinoids and synthetic stimulants in first and second generation legal highs by ultra-performance liquid chromatography with time of flight mass spectrometry (UPLC/ToF). Journal of Analytical Toxicology, 36, 360-371.
5. Indiana Code 35-41-1. http://www.in.gov/legislative/ic/code/ title35/ar41/ch1.html#IC35-41-1-26.3 (1 March 2013, date last accessed).
6. Drug Enforcement Administration. (2013) Establishment of drug codes for 26 substances. Federal Register. Vol. 78, No. 3.
7. Huffman, J.W., Mabon, R., Wu, M.J., Lu, J., Hart, R., Hurst, D.P. et al. (2003) 3-indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB(1) cannabinoid receptor. Bioorganic and Medicinal Chemistry, 11, 539-549.
8. Huffman, J.W., Zengin, G., Wu, M.J., Lu, J., Hynd, G., Bushell, K. et al. (2005) Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB(1) and CB(2) receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB(2) receptor agonists. Bioorganic and Medicinal Chemistry, 13, 89-112.
9. Makriyannis, A., Deng, H. (2005) Cannabimimetic indole derivatives. United States Patent, US 7,241,799 B2.
10. Simolka, K., Lindigkeit, R., Schiebel, H.M., Papke, U., Ernst, L., Beuerle, T. (2012) Analysis of synthetic cannabinoids in 'spice like' herbal highs: snapshot of the German market in summer 2011. Analytical and Bioanalytical Chemistry, 404, 157-171.
11. Uchiyama, N., Kawamura, M., Kikura-Hanajiri, R., Goda, Y. (2013) URB-754: A new class of designer drug and 12 synthetic cannabinoids detected in illegal products. Forensic Science International, 221, 21-32.
12. Yao, B.B., Hsieh, G.C., Frost, J.M., Fan, Y., Garrison, T.R., Daza, A.V. et al. (2008) In vitro and in vivo characterization of A-796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain models. British Journal of Pharmacology, 153, 390-401.
13. Frost, J.M., Dart, M.J., Tietje, K.R., Garrison, T.R., Grayson, G.K., Daza, A.V. et al. (2008) Indol-3-yl-tetramethylcyclopropyl ketones: Effects of indole ring substitution on CB2 cannabinoid receptor activity. Journal of Medicinal Chemistry, 51, 1904-1912.
14. Frost, J.M., Dart, M.J., Tietje, K.R., Garrison, T.R., Grayson, G.K., Daza, A.V. et al. (2010) Indol-3-ylcycloalkyl ketones: effects of N1 substituted indole side chain variations on CB(2) cannabinoid receptor activity. Journal of Medicinal Chemistry, 53, 295-315.
15. Sobolevsky, T., Prosolov, I., Rodchenkov, G. (2012) Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids. Drug Testing and Analysis, 4, 745-753.
16. Kavanagh, P., Grigoryev, A., Savchuk, S., Mikhura, I., Formanovsky, A. (2013) UR-144 in products sold via the Internet: identification of related compounds and characterization of pyrolysis products. Drug Testing and Analysis. doi:10.1002/dta.1456.
17. Alexander, J.P., Cravatt, B.F. (2005) Mechanism of carbamate inactivation of FAAH: implications for the design of covalent inhibitors and in vivo functional probes for enzymes. Chemistry and Biology, 12, 1179-1187.
18. Piomelli, D., Tarzia, G., Duranti, A., Tontini, A., Mor, M., Compton, T.R. et al. (2006) Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597). CNS Drug Reviews, 12, 21-38.
19. Clapper, J.R., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Piomelli, D. (2006) The fatty-acid amide hydrolase inhibitor URB597 does not affect triacylglycerol hydrolysis in rat tissues. Pharmacological Research, 54, 341-344.
20. Russo, R., Loverme, J., La Rana, G., Compton, T.R., Parrott, J., Duranti, A. et al. (2007) The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 30-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice. Journal of Pharmacology and Experimental Therapeutics, 322, 236-242.
21. Solinas, M., Tanda, G., Justinova, Z., Wertheim, C.E., Yasar, S., Piomelli, D. et al. (2007) The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport. Journal of Pharmacology and Experimental Therapeutics, 321, 370-380.
22. Schlosburg, J.E., Kinsey, S.G., Lichtman, A.H. (2009) Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation. AAPS Journal, 11, 39-44.